{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:28:27Z","timestamp":1790771307889,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,5,7]],"date-time":"2018-05-07T00:00:00Z","timestamp":1525651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Uitzicht"},{"name":"Stichting Leids Oogheelkundig Ondersteuningsfonds"},{"DOI":"10.13039\/501100010372","name":"Rotterdamse stichting Blindenbelangen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010372","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Haagse stichting Blindenhulp"},{"name":"Stichting Ooglijders"},{"name":"Gisela Thier Fellowship"},{"name":"VENI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00417-018-4003-z","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T19:59:39Z","timestamp":1525636779000},"page":"1395-1402","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Clinical characteristics of chronic central serous chorioretinopathy patients with insufficient response to reduced-settings photodynamic therapy"],"prefix":"10.1007","volume":"256","author":[{"given":"Thomas J.","family":"van Rijssen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elon H. C.","family":"van Dijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greet","family":"Dijkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel J. F.","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,7]]},"reference":[{"key":"4003_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/opth.s115685","volume":"11","author":"MB Breukink","year":"2017","unstructured":"Breukink MB, Dingemans AJ, den Hollander AI, Keunen JE, MacLaren RE, Fauser S, Querques G, Hoyng CB, Downes SM, Boon CJ (2017) Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol 11:39\u201346. \n                    https:\/\/doi.org\/10.2147\/opth.s115685","journal-title":"Clin Ophthalmol"},{"key":"4003_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","volume":"48","author":"A Daruich","year":"2015","unstructured":"Daruich A, Matet A, Dirani A, Bousquet E, Zhao M, Farman N, Jaisser F, Behar-Cohen F (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82\u2013118. \n                    https:\/\/doi.org\/10.1016\/j.preteyeres.2015.05.003","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"4003_CR3","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1097\/IAE.0b013e3181be0a83","volume":"29","author":"Y Imamura","year":"2009","unstructured":"Imamura Y, Fujiwara T, Margolis R, Spaide RF (2009) Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 29(10):1469\u20131473. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e3181be0a83","journal-title":"Retina"},{"issue":"2","key":"4003_CR4","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C (2013) Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 58(2):103\u2013126. \n                    https:\/\/doi.org\/10.1016\/j.survophthal.2012.07.004","journal-title":"Surv Ophthalmol"},{"issue":"9","key":"4003_CR5","doi-asserted-by":"publisher","first-page":"5229","DOI":"10.1167\/iovs.15-17140","volume":"56","author":"MM Teussink","year":"2015","unstructured":"Teussink MM, Breukink MB, van Grinsven MJ, Hoyng CB, Klevering BJ, Boon CJ, de Jong EK, Theelen T (2015) OCT angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Invest Ophthalmol Vis Sci 56(9):5229\u20135237. \n                    https:\/\/doi.org\/10.1167\/iovs.15-17140","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"4003_CR6","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1097\/iae.0000000000001064","volume":"36","author":"SY Chan","year":"2016","unstructured":"Chan SY, Wang Q, Wei WB, Jonas JB (2016) Optical coherence tomographic angiography in central serous chorioretinopathy. Retina 36(11):2051\u20132058. \n                    https:\/\/doi.org\/10.1097\/iae.0000000000001064","journal-title":"Retina"},{"issue":"3","key":"4003_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00006982-199616030-00004","volume":"16","author":"RF Spaide","year":"1996","unstructured":"Spaide RF, Hall L, Haas A, Campeas L, Yannuzzi LA, Fisher YL, Guyer DR, Slakter JS, Sorenson JA, Orlock DA (1996) Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 16(3):203\u2013213","journal-title":"Retina"},{"issue":"2","key":"4003_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.ophtha.2003.09.024","volume":"111","author":"R Haimovici","year":"2004","unstructured":"Haimovici R, Koh S, Gagnon DR, Lehrfeld T, Wellik S (2004) Risk factors for central serous chorioretinopathy: a case-control study. Ophthalmology 111(2):244\u2013249. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2003.09.024","journal-title":"Ophthalmology"},{"issue":"2","key":"4003_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/iae.0000000000001138","volume":"37","author":"CK Cheng","year":"2017","unstructured":"Cheng CK, Chang CK, Peng CH (2017) Comparison of photodynamic therapy using half-dose of verteporfin or half-fluence of laser light for the treatment of chronic central serous chorioretinopathy. Retina 37(2):325\u2013333. \n                    https:\/\/doi.org\/10.1097\/iae.0000000000001138","journal-title":"Retina"},{"issue":"3","key":"4003_CR10","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/00006982-200306000-00002","volume":"23","author":"LA Yannuzzi","year":"2003","unstructured":"Yannuzzi LA, Slakter JS, Gross NE, Spaide RF, Costa D, Huang SJ, Klancnik JM Jr, Aizman A (2003) Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: a pilot study. Retina 23(3):288\u2013298","journal-title":"Retina"},{"key":"4003_CR11","doi-asserted-by":"publisher","unstructured":"Salehi M, Wenick AS, Law HA, Evans JR, Gehlbach P (2015) Interventions for central serous chorioretinopathy: a network meta-analysis. Cochrane Database Syst Rev (12):Cd011841. doi:\n                    https:\/\/doi.org\/10.1002\/14651858.CD011841.pub2","DOI":"10.1002\/14651858.CD011841.pub2"},{"key":"4003_CR12","first-page":"T8","volume":"113","author":"TY Lai","year":"2015","unstructured":"Lai TY, Wong RL, Chan WM (2015) Long-term outcome of half-dose verteporfin photodynamic therapy for the treatment of central serous chorioretinopathy (an American Ophthalmological Society thesis). Trans Am Ophthalmol Soc 113:T8","journal-title":"Trans Am Ophthalmol Soc"},{"key":"4003_CR13","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ajo.2016.04.001","volume":"167","author":"HY Liu","year":"2016","unstructured":"Liu HY, Yang CH, Yang CM, Ho TC, Lin CP, Hsieh YT (2016) Half-dose versus half-time photodynamic therapy for central serous chorioretinopathy. Am J Ophthalmol 167:57\u201364. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2016.04.001","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"4003_CR14","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1089\/jop.2016.0184","volume":"33","author":"SY Peng","year":"2017","unstructured":"Peng SY, Lai CC, Wang NK, Wu WC, Hwang YS, Chen KJ, Chen LJ, Tsai S, Chan WC, Liu L, Yeung L (2017) Real-world experience with half-time versus half-dose photodynamic therapy in chronic central serous chorioretinopathy. J Ocul Pharmacol Ther 33(6):466\u2013472. \n                    https:\/\/doi.org\/10.1089\/jop.2016.0184","journal-title":"J Ocul Pharmacol Ther"},{"issue":"12","key":"4003_CR15","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/bjo.87.12.1453","volume":"87","author":"WM Chan","year":"2003","unstructured":"Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK (2003) Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol 87(12):1453\u20131458","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"4003_CR16","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1007\/s00417-002-0517-4","volume":"240","author":"U Schlotzer-Schrehardt","year":"2002","unstructured":"Schlotzer-Schrehardt U, Viestenz A, Naumann GO, Laqua H, Michels S, Schmidt-Erfurth U (2002) Dose-related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefe\u2019s Arch Clin Exp Ophthalmol 240(9):748\u2013757. \n                    https:\/\/doi.org\/10.1007\/s00417-002-0517-4","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"issue":"8","key":"4003_CR17","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1136\/bjophthalmol-2014-305353","volume":"99","author":"CC Tseng","year":"2015","unstructured":"Tseng CC, Chen SN (2015) Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy. Br J Ophthalmol 99(8):1070\u20131077. \n                    https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305353","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"4003_CR18","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.ajo.2011.08.015","volume":"153","author":"M Nicolo","year":"2012","unstructured":"Nicolo M, Zoli D, Musolino M, Traverso CE (2012) Association between the efficacy of half-dose photodynamic therapy with indocyanine green angiography and optical coherence tomography findings in the treatment of central serous chorioretinopathy. Am J Ophthalmol 153(3):474\u2013480.e471. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2011.08.015","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"4003_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/aos.12938","volume":"94","author":"MB Breukink","year":"2016","unstructured":"Breukink MB, Mohr JK, Ossewaarde-van Norel A, den Hollander AI, Keunen JE, Hoyng CB, Boon CJ (2016) Half-dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Acta Ophthalmol 94(2):187\u2013197. \n                    https:\/\/doi.org\/10.1111\/aos.12938","journal-title":"Acta Ophthalmol"},{"key":"4003_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ajo.2016.07.026","volume":"170","author":"FH Lai","year":"2016","unstructured":"Lai FH, Ng DS, Bakthavatsalam M, Chan VC, Young AL, Luk FO, Tsang CW, Brelen ME (2016) A multicenter study on the long-term outcomes of half-dose photodynamic therapy in chronic central serous chorioretinopathy. Am J Ophthalmol 170:91\u201399. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2016.07.026","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"4003_CR21","doi-asserted-by":"publisher","first-page":"e0181479","DOI":"10.1371\/journal.pone.0181479","volume":"12","author":"F Haga","year":"2017","unstructured":"Haga F, Maruko R, Sato C, Kataoka K, Ito Y, Terasaki H (2017) Long-term prognostic factors of chronic central serous chorioretinopathy after half-dose photodynamic therapy: a 3-year follow-up study. PLoS One 12(7):e0181479. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0181479","journal-title":"PLoS One"},{"issue":"3","key":"4003_CR22","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ajo.2009.10.011","volume":"149","author":"R Inoue","year":"2010","unstructured":"Inoue R, Sawa M, Tsujikawa M, Gomi F (2010) Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 149(3):441\u2013446.e441\u2013442. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2009.10.011","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"4003_CR23","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1097\/IAE.0b013e3181d87e04","volume":"30","author":"NZ Gregori","year":"2010","unstructured":"Gregori NZ, Feuer W, Rosenfeld PJ (2010) Novel method for analyzing snellen visual acuity measurements. Retina 30(7):1046\u20131050. \n                    https:\/\/doi.org\/10.1097\/IAE.0b013e3181d87e04","journal-title":"Retina"},{"key":"4003_CR24","doi-asserted-by":"publisher","unstructured":"Matet A, Daruich A, Zola M, Behar-Cohen F (2017) Risk factors for recurrences of central serous chorioretinopathy. Retina. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000001729","DOI":"10.1097\/IAE.0000000000001729"},{"issue":"3","key":"4003_CR25","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.ophtha.2014.09.034","volume":"122","author":"K Fujita","year":"2015","unstructured":"Fujita K, Imamura Y, Shinoda K, Matsumoto CS, Mizutani Y, Hashizume K, Mizota A, Yuzawa M (2015) One-year outcomes with half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy. Ophthalmology 122(3):555\u2013561. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2014.09.034","journal-title":"Ophthalmology"},{"issue":"1","key":"4003_CR26","doi-asserted-by":"publisher","first-page":"e0169152","DOI":"10.1371\/journal.pone.0169152","volume":"12","author":"G Chen","year":"2017","unstructured":"Chen G, Tzekov R, Li W, Jiang F, Mao S, Tong Y (2017) Subfoveal choroidal thickness in central serous chorioretinopathy: a meta-analysis. PLoS One 12(1):e0169152. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0169152","journal-title":"PLoS One"},{"issue":"12","key":"4003_CR27","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/eye.2010.130","volume":"24","author":"M Gemenetzi","year":"2010","unstructured":"Gemenetzi M, De Salvo G, Lotery AJ (2010) Central serous chorioretinopathy: an update on pathogenesis and treatment. Eye (Lond) 24(12):1743\u20131756. \n                    https:\/\/doi.org\/10.1038\/eye.2010.130","journal-title":"Eye (Lond)"},{"issue":"9","key":"4003_CR28","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1016\/j.ophtha.2010.01.023","volume":"117","author":"I Maruko","year":"2010","unstructured":"Maruko I, Iida T, Sugano Y, Ojima A, Ogasawara M, Spaide RF (2010) Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 117(9):1792\u20131799. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2010.01.023","journal-title":"Ophthalmology"},{"issue":"12","key":"4003_CR29","doi-asserted-by":"publisher","first-page":"e0144156","DOI":"10.1371\/journal.pone.0144156","volume":"10","author":"Y Wakatsuki","year":"2015","unstructured":"Wakatsuki Y, Shinojima A, Kawamura A, Yuzawa M (2015) Correlation of aging and segmental choroidal thickness measurement using swept source optical coherence tomography in healthy eyes. PLoS One 10(12):e0144156. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0144156","journal-title":"PLoS One"},{"key":"4003_CR30","doi-asserted-by":"publisher","first-page":"16003","DOI":"10.1038\/npjamd.2016.3","volume":"2","author":"JB Lin","year":"2016","unstructured":"Lin JB, Tsubota K, Apte RS (2016) A glimpse at the aging eye. NPJ Aging Mech Dis 2:16003. \n                    https:\/\/doi.org\/10.1038\/npjamd.2016.3","journal-title":"NPJ Aging Mech Dis"},{"issue":"6","key":"4003_CR31","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/S0002-9394(02)01438-1","volume":"133","author":"MS Wang","year":"2002","unstructured":"Wang MS, Sander B, Larsen M (2002) Retinal atrophy in idiopathic central serous chorioretinopathy. Am J Ophthalmol 133(6):787\u2013793","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"4003_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.ajo.2004.08.037","volume":"139","author":"FC Piccolino","year":"2005","unstructured":"Piccolino FC, de la Longrais RR, Ravera G, Eandi CM, Ventre L, Abdollahi A, Manea M (2005) The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy. Am J Ophthalmol 139(1):87\u201399. \n                    https:\/\/doi.org\/10.1016\/j.ajo.2004.08.037","journal-title":"Am J Ophthalmol"},{"key":"4003_CR33","doi-asserted-by":"publisher","unstructured":"Daruich A, Matet A, Marchionno L, De Azevedo JD, Ambresin A, Mantel I, Behar-Cohen F (2017) Acute central serous chorioretinopathy: factors influencing episode duration. Retina Oct 37(10):1905\u20131915. \n                    https:\/\/doi.org\/10.1097\/IAE.0000000000001443","DOI":"10.1097\/IAE.0000000000001443"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-018-4003-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-018-4003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T06:09:56Z","timestamp":1562911796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-018-4003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,7]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["4003"],"URL":"https:\/\/doi.org\/10.1007\/s00417-018-4003-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,7]]},"assertion":[{"value":"9 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All procedures performed were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}